CHYUNG YUNG H. 4
4 · Keros Therapeutics, Inc. · Filed Nov 12, 2024
Insider Transaction Report
Form 4
CHYUNG YUNG H.
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-11-08+110,000→ 110,000 totalExercise: $67.91Exp: 2034-11-07→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on November 1, 2025, and 6.25% of the shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.